Tobias Cantz, MD

Group Leader
Hannover Medical School, Germany

Poster(s):

• (T1062) Patient-specific iPSC-derived hepatic organoids as model for mRNA-based gene therapy in farnesoid-X receptor (FXR) deficiencies
  Thursday, June 12, 2025

  5:00 PM - 6:00 PM HK Time